[Recent advances in cerebrovascular diseases from the view point of blood coagulation/fibrinolysis]
Related Experiment Video
Updated: Aug 13, 2026

A Comprehensive Approach to Analyze the Cell Components of Cerebral Blood Clots
Published on: July 21, 2023
1Department of Laboratory and Molecular Medicine, Kagoshima University Graduate School of Medicine and Dental Science.
Insights
Cerebrovascular diseases in Japan are linked to unique brain hemostasis. Decreased anticoagulant protein and increased tissue factor promote thrombosis, impacting stroke prevention and treatment.
Area of Science:
- Neuroscience
- Hematology
- Vascular Biology
Context:
- Cerebrovascular diseases (CVD) represent a significant clinical challenge in Japan.
- Understanding the brain's unique hemostatic system is crucial for managing CVD.
- This review focuses on the roles of blood coagulation, fibrinolysis, and platelets in brain circulation.
Purpose:
- To review the patho-mechanisms underlying cerebrovascular diseases.
- To explore prevention and treatment strategies for CVD.
- To highlight the specific characteristics of the hemostatic system in the brain.
Summary:
- The brain exhibits unique hemostatic properties, including decreased expression of thrombomodulin, an anticoagulant endothelial protein.
- This reduction in thrombomodulin may lead to an increased thrombotic tendency in the brain compared to other organs.
- The brain is also rich in tissue factor, which can activate the extrinsic coagulation pathway upon vascular injury, with thrombin regulation being less efficient due to low thrombomodulin.
Impact:
- Provides insights into the specific molecular mechanisms driving cerebrovascular diseases.
- Informs the development of targeted prevention and treatment strategies for stroke and other CVDs.
- Highlights the importance of considering organ-specific hemostatic differences in clinical practice.
Abstract:
Cerebrovascular diseases (CVD) are one of the most serious clinical problem in Japan. Here we review patho-mechanism, prevention and treatment of CVD, from the view point of blood coagulation/fibrinolysis and platelets. The hemostatic system is quite unique in the brain. One of the characteristic functional and structural basis of circulation is decreased expression of thromobomodulin, an anticoagulant endothelial protein in the brain. This may cause thrombotic tendency in the brain compared to other organs. Another characteristics is rich in tissue factor in the brain. Thus once vascular vessels are injured, circulatory factor VII may interact with the tissue factor and result activation of extrinsic coagulation pathway. Generated thrombin could not be regulated efficiently like other organs, because of decreased expression of thrombomodulin.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Hemorrhagic Stroke ll: Pathophysiology
Venous Thrombosis III: Interprofessional Care
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

